Cyclisation strategies for stabilising peptides with irregular conformations
- 28 April 2021
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 12 (6) , 887-901
Abstract
There are remarkably few examples of designing cyclic constraints for peptides which adopt an irregular conformation in their bioactive state. We discuss the design strategies, opportunities and challenges for this underexplored class of inhibitors.Keywords
Funding Information
- Australian Research Council (DE190100624)
- Westpac Scholars Trust (WRF2020)
- National Health and Medical Research Council (APP2003250)
- Agency for Science, Technology and Research (H17/01/a0/010)
This publication has 92 references indexed in Scilit:
- Future directions for peptide therapeutics developmentDrug Discovery Today, 2013
- A Unified Conformational Selection and Induced Fit Approach to Protein-Peptide DockingPLOS ONE, 2013
- On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffoldsNature Chemical Biology, 2011
- Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their ReceptorsPLOS ONE, 2011
- Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic InhibitorsACS Chemical Biology, 2010
- Sub-angstrom modeling of complexes between flexible peptides and globular proteinsProteins: Structure, Function, and Bioinformatics, 2010
- Contemporary strategies for the stabilization of peptides in the α-helical conformationCurrent Opinion in Chemical Biology, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Characterization of Protein–Protein InterfacesThe Protein Journal, 2007
- Ligand configurational entropy and protein bindingProceedings of the National Academy of Sciences, 2007